LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media

By
Media Outreach
-
0
HANOI, VIETNAM – Media OutReach Newswire – 19 May 2025 – LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking international scientific journal Scientific Reports-Nature, recognizing its effectiveness in supporting the treatment of rhinosinusitis and otitis media in children. This marks the third consecutive study on the product published in a prestigious international scientific platform, reinforcing a promising new direction in non-antibiotic respiratory care.

https://livespo.com

The issuer is solely responsible for the content of this announcement.

About LiveSpo Pharma

LiveSpo is an R&D, manufacturing, and distribution brand of Clinically Proven Medical Probiotics, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for “A Future Without Antibiotics”.

Our vision: In 2027, LiveSpo will have 1.5 million consumers who use Spore probiotics for digestive and respiratory health instead of antibiotics, with outstanding benefits and customer experiences. Established since 2010 by Dr. Nguyen Hoa Anh (Dr. ANH) and his colleagues, LiveSpo has remained steadfast in its belief that Live Probiotic Spores – Spobiotic – will pave the way to a future without antibiotics for everyone.

Hotline: 1800.088808

Website: